CÁNCER DE MAMA
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Biogipuzkoa (25)
2024
-
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer
Breast Cancer Research, Vol. 26, Núm. 1
-
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant eR+ breast cancer
Science Translational Medicine, Vol. 16, Núm. 736
2023
-
Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature
Frontiers in Immunology, Vol. 14
-
Evaluating gender awareness, gender-related health knowledge and patient pain legitimation among nursing students: A quasi-experimental study
Nurse Education in Practice, Vol. 72
-
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung Cancer
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 14, pp. 2561-2570
-
Germline gain-of-function MMP11 variant results in an aggressive form of colorectal cancer
International Journal of Cancer, Vol. 152, Núm. 2, pp. 283-297
-
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer
Nature Communications, Vol. 14, Núm. 1
-
New perspectives in cancer immunotherapy: targeting IL-6 cytokine family
Journal for immunotherapy of cancer, Vol. 11, Núm. 11
2022
-
Health care costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component
Gaceta Sanitaria, Vol. 36, Núm. 3, pp. 246-252
-
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Journal of Clinical Investigation, Vol. 132, Núm. 7
2021
-
Discovery and proof-of-concept study of nuclease activity as a novel biomarker for breast cancer tumors
Cancers, Vol. 13, Núm. 2, pp. 1-16
-
The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer
Cancers, Vol. 13, Núm. 21
-
The role of the il-6 cytokine family in epithelial–mesenchymal plasticity in cancer progression
International Journal of Molecular Sciences, Vol. 22, Núm. 15
2020
-
MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum
Journal of Clinical Oncology, Vol. 38, Núm. 32, pp. 3753-3762
-
Preliminary Qualitative and Quantitative Evaluation of DESIREE, a Decision Support Platform for the Management of Primary Breast Cancer Patients
AMIA ... Annual Symposium proceedings. AMIA Symposium, Vol. 2020, pp. 1012-1021
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2
-
What accounts for physical activity during pregnancy? A study on the sociodemographic predictors of self-reported and objectively assessed physical activity during the 1st and 2nd trimesters of pregnancy
International Journal of Environmental Research and Public Health, Vol. 17, Núm. 7
2019
-
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
Aging, Vol. 11, Núm. 9, pp. 2874-2888
-
Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer
Journal of Clinical Medicine, Vol. 8, Núm. 12
-
The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin
Frontiers in Oncology, Vol. 9, Núm. MAR